国际医药卫生导报 ›› 2024, Vol. 30 ›› Issue (21): 3589-3593.DOI: 10.3760/cma.j.issn.1007-1245.2024.21.014

• 论著 • 上一篇    下一篇

不同途径营养支持方式在肾部分切除术治疗易位性肾细胞癌患者中的应用效果

闫家文1  卫姝岑2   

  1. 1商洛市中心医院泌尿外科,商洛 726000;2商洛市中心医院营养科,商洛 726000

  • 收稿日期:2024-06-05 出版日期:2024-11-01 发布日期:2024-11-12
  • 通讯作者: 卫姝岑,Email:15891379967@163.com
  • 基金资助:

    陕西省自然科学基础研究计划(2020JQ-945)

Effects of partial nephrectomy combined with different nutritional support methods for patients with ectopic renal cell carcinoma

Yan Jiawen1, Wei Shucen2   

  1. 1 Department of Urology, Shangluo Central Hospital, Shangluo 726000, China; 2 Department of Nutrition, Shangluo Central Hospital, Shangluo 726000, China

  • Received:2024-06-05 Online:2024-11-01 Published:2024-11-12
  • Contact: Wei Shucen, Email: 15891379967@163.com
  • Supported by:

    Basic Research Plan of Natural Science in Shaanxi (2020JQ-945)

摘要:

目的 探讨不同途径营养支持方式在肾部分切除术治疗易位性肾细胞癌患者中的应用效果。方法 前瞻性研究,选取2021年2月至2023年4月在商洛市中心医院泌尿外科行肾部分切除术治疗的74例易位性肾细胞癌患者作为研究对象,通过电脑随机编码方式分为肠外组(37例)和肠内组(37例)。肠外组男11例、女26例,年龄(45.83±4.67)岁,在常规治疗基础上给予肠外营养支持方案;肠内组男13例、女24例,年龄(45.57±4.33)岁,给予肠内营养支持方案。对比两组患者干预前后营养指标[血红蛋白(Hb)、白蛋白(Alb)、转铁蛋白(TRF)、前白蛋白(PA)]、免疫指标[CD3+、CD4+、CD8+]、炎症因子[肿瘤坏死因子-α(TNF-α)、白介素(IL)-6、IL-8]及干预期间不良反应发生情况。统计学方法t检验、χ2检验。结果 干预前,两组患者Hb、Alb、TRF、PA、CD3+、CD4+、CD8+及TNF-α、IL-6、IL-8水平比较,差异均无统计学意义(均P>0.05)。干预后,肠内组Hb、Alb、TRF、PA、CD3+、CD4+均高于肠外组[(126.73±11.26)g/L比(117.89±11.03)g/L、(37.41±5.88)g/L比(32.76±5.92)g/L、(2.98±0.44)g/L比(2.67±0.46)g/L、(239.73±23.70)mg/L比(217.46±22.54)mg/L、(51.30±5.86)%比(42.58±5.07)%、(42.67±3.46)%比(37.34±3.41)],CD8+及TNF-α、IL-6、IL-8水平均低于肠外组[(27.57±3.19)%比(33.46±3.27)%、(18.46±2.57)ng/L比(22.34±2.73)ng/L、(43.26±4.35)ng/L比(54.67±4.97)ng/L、(37.92±4.08)mg/L比(42.26±4.31)mg/L],差异均有统计学意义(t=3.411、3.390、2.962、4.142、6.845、6.674、7.842、6.295、10.508、4.448,均P<0.05)。干预期间,两组患者不良反应发生情况比较,差异无统计学意义(χ2=0.725,P=0.394)。结论 肠内营养支持方案可以改善肾部分切除术后易位性肾细胞癌患者营养状况、免疫功能及炎症水平。

关键词:

肾细胞癌, 肾部分切除术, 营养支持, 免疫功能, 炎症因子

Abstract:

Objective To explore the effects of different nutritional support methods for patients with translocated renal cell carcinoma undergoing partial nephrectomy. Methods This prospective study included 74 patients with ectopic renal cell carcinoma who underwent partial nephrectomy at Department of Urology, Shangluo Central Hospital from February 2021 to April 2023. The patients were divided a parenteral nutrition group (37 cases) and an enteral nutrition group (37 cases) by computer coding. There were 11 males and 26 females in the parenteral nutrition group; they were (45.83±4.67) years old. There were 13 males and 24 females in the enteral nutrition group; they (45.57±4.33) years old. The parenteral nutrition group took parenteral nutritional support on the basis of standard care. The enteral nutrition group took enteral nutritional support. The nutritional parameters [hemoglobin (Hb), albumin (Alb), transferrin (TRF), and prealbumin (PA)], immune markers (CD3+, CD4+, and CD8+), and inflammatory factors [tumor necrosis factor-α (TNF-α), interleukin (IL)-6, and IL-8] before and after the intervention and incidences of adverse reactions during the intervention were compared between the two groups by t and χ2 tests. Results Before the intervention, there were no statistical differences in the levels of Hb, Alb, TRF, PA, CD3+, CD4+, CD8+, TNF-α, IL-6, and IL-8 between the two groups (all P>0.05). After the intervention, the levels of Hb, Alb, TRF, PA, CD3+, and CD4+ in the enteral nutrition group were higher than those in the parenteral nutrition group [(126.73±11.26) g/L vs. (117.89±11.03) g/L, (37.41±5.88) g/L vs. (32.76±5.92) g/L, (2.98±0.44) g/L vs. (2.67±0.46) g/L, (239.73±23.70) mg/L vs. (217.46±22.54) mg/L, (51.30±5.86)% vs. (42.58±5.07)%, and (42.67±3.46)% vs. (37.34±3.41)]; the levels of CD8+, TNF-α, IL-6, and IL-8 in the enteral nutrition group were lower than those in the parenteral nutrition group [(27.57±3.19)% vs. (33.46±3.27)%, (18.46±2.57) ng/L vs. (22.34±2.73) ng/L, (43.26±4.35) ng/L vs. (54.67±4.97) ng/L, and (37.92±4.08) mg/L vs. (42.26±4.31) mg/L]; there were statistical differences (t=3.411, 3.390, 2.962, 4.142, 6.845, 6.674, 7.842, 6.295, 10.508, and 4.448; all P<0.05). There was no statistical difference in the incidence of adverse reactions between the two groups during the intervention (χ2=0.725; P=0.394). Conclusion Enteral nutritional support can improve the nutritional status, immune function, and inflammatory levels in patients with ectopic renal cell carcinoma after partial nephrectomy.

Key words:

Renal cell carcinoma, Partial nephrectomy, Nutritional support, Immune function, Inflammatory cytokines